Pharvaris N.V.

PHVS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001830487

SEC filings (opens in a new tab)

In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.

Q1 2022 vs. Q4 2021

How the institutions holding Pharvaris N.V. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of PHVS: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	22	22	0
Shares	21.6M	21.7M	+38.4K (+0.2%)
Value	$321.1M	$397.1M	+$76.0M (+23.7%)

New holders (1)

Institutions that held Pharvaris N.V. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to PHVS in Q1 2022
Institution	Shares	Value	% of portfolio
Tower Research Capital LLC (TRC)	77	$1.00K	0.00%

Sold out (1)

Institutions that held Pharvaris N.V. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of PHVS in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Perceptive Advisors LLC	27,000	$389.0K